Since enrollment in ABSORB III was restricted to patients with relatively stable symptoms and noncomplex coronary lesions, it is likely that results from this study cannot be generalized (as mentioned). What are the main contraindications when considering loosening the patient enrollment criteria? Is there an excluded population that may benefit from this study?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.